3, 5 timer hos forsøgspersoner med kreatinin- clearance > 50 ml/ min til mere end 9 timer hos forsøgspersoner med nedsat nyrefunktion < 50 ml/ min.
The half-life of lenalidomide increased from approximately 3.5 hours in subjects with creatinine clearance > 50 ml/min to more than 9 hours in subjects with reduced renal function < 50 ml/min.